Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

T. Rowe Price Equity Index 500 Fund (PREIX)

56.55
Net Asset Value
-0.28%
1 Day
+1.95%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
0.27%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks to track the performance of a benchmark index that measures the investment return of large-capitalization U.S. stocks. The fund attempts to match the investment return of large-capitalization U.S. stocks by seeking to match the performance of its benchmark index, the S&P 500. Under normal conditions, the fund will invest at least 80% of its net assets (including any borrowings for investment purposes) in stocks that are held in its benchmark index. T. Rowe Price compares the composition of the fund to that of the index.

Performance

1 month+1.09% 3 years+16.82%
3 months-0.05% 5 years+15.48%
1 year+10.95% Since inception+9.39%
Data through --

Peer Comparisonvs. Large blend

 PREIXCategory
Performance 5-yr return+15.48%+15.84%
Expense ratio0.27%1.10%
Risk 5 year sharpe ratio1.371.23
Net assets$25.3B$3.8B
Average market cap$72.4B$102.0B
Average P/E19.018.1
Portfolio turnover6%6%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyT. Rowe Price
Fund manager & tenureE. Bair / 12 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock97.61%
International stock1.28%
Cash1.08%
Fixed income0.02%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 16.43%
Energy 12.42%
Industrial materials 12.18%
Healthcare 11.11%
Hardware 9.24%
Top 10 Holdings
Portfolio weighting
AAPL Apple3.92%
MSFT Microsoft1.94%
XOM Exxon Mobil1.88%
JNJ Johnson & Johnson1.47%
GE General Electric1.45%
WFC Wells Fargo1.43%
JPM JPMorgan Chase1.36%
BRKB Berkshire Hathaway1.35%
PG Procter & Gamble1.15%
PFE Pfizer1.12%